Evidence map›Paper›PMID 23382955›Full record

ArticlePloS one2013

Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?

Alice Zwerling, Andrea Benedetti, Mihaela Cojocariu, Fiona McIntosh, Filomena Pietrangelo, Marcel A Behr, Kevin Schwartzman, Dick Menzies, Madhukar Pai

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. Low TB1 and TB2 antigen-nil is associated with increased QuantiFERON Gold Plus reversions.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2026
    Article
  3. Article
  4. Variability of interferon-γ release assays in people at high risk of tuberculosis infection or progression to tuberculosis disease living in the United States.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2022
    Article
  5. Article
  6. In the time of strategies to end tuberculosis, prevention is better than treatment.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2020
    Article
  7. Article
  8. Paradox of serial interferon-gamma release assays: variability width more important than specificity size.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2018
    Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Alice ZwerlingDepartment of Epidemiology, Biostatistics & Occupational Health, McGill University, Montreal, Canada.
Andrea Benedetti
Mihaela Cojocariu
Fiona McIntosh
Filomena Pietrangelo
Marcel A Behr
Kevin Schwartzman
Dick Menzies
Madhukar Pai
McGill University · CAMcGill University Health Centre · CAMontreal Heart Institute · CA

Funding

Canadian Institutes of Health Research 81362
6 · The paper itself

Abstract

backgroundAlthough North American hospitals are switching from tuberculin testing (TST) to interferon-gamma release assays (IGRAs), data are limited on the association between occupational exposure and serial QuantiFERON-TB Gold In-Tube (QFT) results in healthcare workers (HCWs).

methodsIn a cohort of Canadian HCWs, TST and QFT were performed at study enrolment (TST1 and QFT1) and 1 year later (TST2 and QFT2). Conversion and reversion rates were estimated, and correlation with TB exposure was assessed.

resultsAmong 258 HCWs, median age was 36.8 years, 188/258 (73%) were female and 183/258 (71%) were Canadian-born. In 245 subjects with a negative QFT1 we found a QFT conversion rate of 5.3% (13/245, 95% CI 2.9-8.9%). Using more stringent definitions, QFT conversion rates ranged from 2.0 to 5.3%. No TST conversions were found among the 241 HCWs with negative TST1, and no measure of recent TB exposure was associated with QFT conversions. In the 13 HCWs with a positive QFT1, 62% reverted.

conclusionUsing the conventional QFT conversion definition, we found a higher than expected rate of conversion. Recent occupational exposures were not associated with QFT conversions, and no TST conversions occurred in this cohort, suggesting the 'conversions' may not reflect new TB infection.

Indexed as

Health PersonnelInterferon-gamma Release TestsOccupational ExposureAdultCanadaCohort StudiesFemaleHumansMaleMass ScreeningMiddle AgedMycobacterium tuberculosisSensitivity and SpecificityTuberculin TestTuberculosisYoung Adult

Identifiers

PMID23382955
PMCPMC3561382
OpenAlexW2053651256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.